Welcome to Galapagos

Galapagos seeks to develop a robust portfolio of clinical-stage breakthrough therapies that have the potential to revolutionize existing treatment paradigms. Our ambition is to become a leading global biotechnological company, focused on the development and commercialization of novel medicines that will improve people’s lives.

Learn more about Galapagos

Novel targets, better treatments

Watch our target discovery animation. 

Read more



Galapagos’ most advanced candidate drug filgotinib shows excellent safety and efficacy in rheumatoid arthritis patients.

Read more

Our latest publications at ACR 2015